Blar i HV - Institutt for naturvitenskapelige helsefag på tidsskrift "European Radiology"
Viser treff 1-5 av 5
-
Halved contrast medium dose in lower limb dual-energy computed tomography angiography—a randomized controlled trial
(Peer reviewed; Journal article, 2023)Objectives To compare vascular attenuation (VA) of an experimental half iodine-load dual-layer spectral detector CT (SDCT) lower limb computed tomography angiography (CTA) with control (standard iodine-load conventional ... -
Indirect CT venography of the lower extremities: impact of scan delay and patient factors on contrast enhancement and examination quality
(European Radiology;Volume 32, issue 11, Peer reviewed; Journal article, 2022-05-12)Objectives Indirect computed tomography venography (CTV) is often the next imaging modality for deep vein thrombosis (DVT) when sonography is inconclusive. Our aim was to investigate the impact of scan delay and patient ... -
Radiological review of prior screening mammograms of screen-detected breast cancer
(European Radiology;, Journal article; Peer reviewed, 2020-10-01)Objective: To perform a radiological review of mammograms from prior screening and diagnosis of screen-detected breast cancer in BreastScreen Norway, a population-based screening program. Methods: We performed a ... -
A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial
(European Radiology;March 2019, Volume 29, Issue 3, Journal article; Peer reviewed, 2018-08-29)Objectives: To describe a randomized controlled trial (RCT) of digital breast tomosynthesis including synthesized two dimensional mammograms (DBT) versus digital mammography (DM) in a population-based screening program for ... -
Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review
(European Radiology;, Journal article; Peer reviewed, 2020-11-12)Objectives: “True” breast cancers, defined as not being visible on prior screening mammograms, are expected to be more aggressive than “missed” cancers, which are visible in retrospect. However, the evidence to support ...